VIRIDIAN THERAPEUTICS INC's ticker is VRDN and the CUSIP is 92790C104. A total of 43 filers reported holding VIRIDIAN THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,161,557 | -36.2% | 401,666 | -1.0% | 0.00% | -50.0% |
| Q2 2023 | $9,655,529 | +2.3% | 405,865 | +9.4% | 0.00% | 0.0% |
| Q1 2023 | $9,436,356 | -10.7% | 370,926 | +2.6% | 0.00% | 0.0% |
| Q4 2022 | $10,564,936 | +88.8% | 361,689 | +32.6% | 0.00% | +100.0% |
| Q3 2022 | $5,595,000 | +98.2% | 272,811 | +11.8% | 0.00% | 0.0% |
| Q2 2022 | $2,823,000 | +170.4% | 243,956 | +331.9% | 0.00% | – |
| Q1 2022 | $1,044,000 | -11.0% | 56,487 | -4.8% | 0.00% | – |
| Q4 2021 | $1,173,000 | +105.8% | 59,328 | +71.2% | 0.00% | – |
| Q3 2021 | $570,000 | -1.0% | 34,651 | +10.1% | 0.00% | – |
| Q2 2021 | $576,000 | – | 31,467 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 2,699,865 | $78,863,057 | 13.28% |
| COMMODORE CAPITAL LP | 2,020,166 | $59,009 | 8.89% |
| ACUTA CAPITAL PARTNERS, LLC | 396,500 | $11,581,765 | 7.13% |
| Fairmount Funds Management LLC | 1,369,623 | $40,006,688 | 6.35% |
| Paradigm Biocapital Advisors LP | 1,751,167 | $51,151,588 | 6.00% |
| Vivo Capital, LLC | 1,678,207 | $49,020 | 5.64% |
| TCG Crossover Management, LLC | 983,610 | $28,731,248 | 5.07% |
| Kynam Capital Management, LP | 1,034,697 | $30,223,499 | 4.64% |
| Octagon Capital Advisors LP | 824,200 | $24,074,882 | 3.75% |
| Logos Global Management LP | 1,000,000 | $29,210,000 | 3.42% |